Large-scale testing (Phase 3)Active Not RecruitingNCT03164564
What this trial is testing
Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 3,224